Neuphoria Therapeutics 8K
Neuphoria Therapeutics files 8K with SEC, disclosing other events.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.
Related stories
Marcus Corp Reports Quarterly Results Through September 30
Marcus Corp reported results for the quarter ended September 30; no figures were provided.
M impact | EQUITY | Oct 29, 2026, 04:37 PM UTC
Marconi Technologies Awarded U.S. Army Production Order for TRILOS
Marconi Technologies was awarded a production order to modernize TRILOS by the U.S. Army.
L impact | EQUITY | Oct 29, 2026, 04:35 PM UTC
Godrej Consumer Q2 Revenue Rises 19% Year on Year
Godrej Consumer Products reported higher revenue for the September quarter of fiscal 2027. Pricing actions and cost savings helped offset rising input costs.
M impact | EQUITY | Oct 29, 2026, 04:35 PM UTC
Higher Freight Rates Add $5.4 Billion to Shell's Debt
Shell said freight rates added $5.4 billion to shipping lease costs in the third quarter versus the previous three months, feeding into net debt. TotalEnergies said freight rates c
M impact | EQUITY | Oct 29, 2026, 04:35 PM UTC
Poundland Files Notice of Intention to Appoint Administrators
M impact | EQUITY | Oct 29, 2026, 04:34 PM UTC
Summi Group Delays Annual Results Publication Due to Audit Procedures
M impact | EQUITY | Oct 29, 2026, 04:34 PM UTC